Lloyd Price
FEBRUARY 23, 2025
Exec Summary As of February 23, 2025, Doximity (NYSE: DOCS), often dubbed the "LinkedIn for Doctors," has shown remarkable strength in the healthcare stock arena, positioning it as a standout performer this year. For the full fiscal year ending March 31, 2025, the company projects revenue between $564.6 million and $565.6
Digital Health Global
DECEMBER 11, 2024
With this acquisition, Gerresheimer strengthens its European footprint with additional production sites and underpins its market position as a leading full-service provider and global partner for the pharma and biotech industries. Gerresheimer expects the acquisition to be accretive to the Group’s Adj. EBITDA margin and Adj.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
MARCH 1, 2025
Exec Summary: The HealthTech M&A landscape in 2025 is characterised by a mix of opportunity and caution. The increase of distressed company M&A's is a large factor in the 2025 market. Average revenue multiples The average revenue multiple for HealthTech companies in March 2025 is 4.8x. This is down from 6.5x
Lloyd Price
DECEMBER 2, 2024
The wound care market is a dynamic and rapidly evolving sector, and 2025 is shaping up to be a pivotal year for innovation and growth in this field. The wound care market is poised for significant growth in 2025 and beyond. These grafts are made from a patient's own cells, which reduces the risk of rejection.
Healthcare IT Today
JULY 18, 2024
Innovative startups in the health IT, medical device, and biotech fields were among the shining stars at the annual Collision conference. In 2025 the conference heads to its new home in Vancouver, BC under its new banner – WebSummit Vancouver. The 2024 conference was held in Toronto, ON for the final time.
Healthcare IT Today
MARCH 13, 2025
With offices in Dallas, Houston, and Austin, GPG Ventures invests nationally in biotech, digital health, medtech, consumer health, and general B2B tech. Originally announced February 3rd, 2025 Affineon integrates seamlessly with EHR systems, saving providers time and enhancing the healthcare experience.
Digital Health Global
NOVEMBER 30, 2023
in 2020, with projections suggesting up to 70% of clinical trials incorporating wearable sensors by 2025. The company will supply solutions to AstraZeneca while extending services to pharma, biotech companies, and clinical research organizations. In a recent review paper appeared on Nature , Mittermaier et al. in 2010 to 11.4%
Expert insights. Personalized for you.
73 
Let's personalize your content